VEGFA and breast cancer: In contrast to studies conducted in Iranian patients, no significant association was found between the variant frequency of VEGFA variants rs3025039, rs2010963, rs833061, and rs35569394 and BC risk or protection [28]; this is similar to findings in the Australian population, where the T allele was considered a protective factor for BC, with an OR of 0.51 [95% CI (0.38–0.70)] [29].